| Literature DB >> 33187324 |
Marta Klimek-Szczykutowicz1, Michał Dziurka2, Ivica Blažević3, Azra Đulović3, Sebastian Granica4, Izabela Korona-Glowniak5, Halina Ekiert1, Agnieszka Szopa1.
Abstract
The main compounds in both extracts were gluconasturtiin, 4-methoxyglucobrassicin and rutoside, the amounts of which were, respectively, determined as 182.93, 58.86 and 23.24 mg/100 g dry weight (DW) in biomass extracts and 640.94, 23.47 and 7.20 mg/100 g DW in plant herb extracts. The antioxidant potential of all the studied extracts evaluated using CUPRAC (CUPric Reducing Antioxidant Activity), FRAP (Ferric Reducing Ability of Plasma), and DPPH (1,1-diphenyl-2-picrylhydrazyl) assays was comparable. The anti-inflammatory activity of the extracts was tested based on the inhibition of 15-lipoxygenase, cyclooxygenase-1, cyclooxygenase-2 (COX-2), and phospholipase A2. The results demonstrate significantly higher inhibition of COX-2 for in vitro cultured biomass compared with the herb extracts (75.4 and 41.1%, respectively). Moreover, all the studied extracts showed almost similar antibacterial and antifungal potential. Based on these findings, and due to the fact that the growth of in vitro microshoots is independent of environmental conditions and unaffected by environmental pollution, we propose that biomass that can be rapidly grown in RITA® bioreactors can serve as an alternative source of bioactive compounds with valuable biological properties.Entities:
Keywords: RITA® bioreactor; anti-inflammatory activity; antibacterial activity; antifungal activity; antioxidant potential; glucosinolates; in vitro cultures; polyphenols; temporary immersion system (TIS)
Mesh:
Substances:
Year: 2020 PMID: 33187324 PMCID: PMC7696031 DOI: 10.3390/molecules25225257
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Microshoot cultures of N. officinale cultivated in bioreactor RITA® TIS on MS medium containing 1 mg/L BA and 1 mg/L NAA after: 10 days of growth period (a); 20 days of growth period (b); and the herb of N. officinale (c).
Total GSLs, polyphenols and flavonoids contents in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant.
| In Vitro Cultures | Plant Material | ||
|---|---|---|---|
| Growth Cycles (Days) | |||
| 10 | 20 | ||
| Total glucosionolates (GSLs) | 261.97 ± 21.14 | 113.70 ± 13.84 | 799.47 ± 4.89 |
| Total polyphenols | 3.74 ± 0.25 | 3.10 ± 0.19 | 2.70 ± 0.31 |
| Total flavonoids | 1.64 ± 0.08 | 0.95 ± 0.03 | 1.89 ± 0.20 |
Data expressed as the mean value ± SD (n = 3), TE—trolox equivalent, RE—rutoside equivalent.
GSLs profile and quantitative content of detected compounds in N. officinale extracts from bioreactor microshoot cultures and the herb of the parent plant confirmed by UHPLC-DAD-MS/MS.
| No. | Glucosinolate (GSL) | [M + Na]+ | Content (mg/100 g DW ± SD) | ||||
|---|---|---|---|---|---|---|---|
| In Vitro Cultures | Plant Material | ||||||
| Growth Cycles (Days) | |||||||
| 10 Days | 20 Days | ||||||
|
| 1 | 6-(Methylsulfinyl)hexyl GSL | 5.20 | 408 | nd | tr | tr |
| 2 | 7-(Methylsulfinyl)heptyl GSL | 6.20 | 422 | tr | tr | 92.27 ± 0.48 | |
| 3 | 8-(Methylsulfinyl)octyl GSL | 7.20 | 436 | tr | tr | 42.79 ± 0.49 | |
| 4 | 7-(Methylsulfanyl)heptyl GSL | 10.60 | 406 | nd | nd | tr | |
| 5 | 8-(Methylsulfanyl)octyl GSL | 12.37 | 420 | nd | nd | tr | |
|
| 6 | 2-Phenylethyl GSL | 7.70 | 366 | 182.93 ± 4.66 | 56.32 ± 7.62 | 640.94 ± 2.96 |
|
| 7 | Indol-3-ylmethyl GSL | 7.00 | 391 | 20.18 ± 4.04 | 7.62 ± 0.01 | tr |
| 8 | 4-Methoxyindol-3-ylmethyl GSL | 7.80 | 421 | 58.86 ± 12.44 | 49.76 ± 6.22 | 23.47 ± 0.96 | |
[M + Na]+, sodium adduct of desulfoglucosinolate; DW, dry weight; tr < 0.1 μmol/g DW; nd, not detected. Data are expressed as the mean value ± SD (n = 3). Met derived—methionine-derived glucosinolates; Phe derived—phenylalanine-derived glucosinolates; Trp derived—tryptophan-derived glucosinolates.
Figure 2Chromatograms of desulfoglucosinolates (dGSLs): RW1—extract of 10-days bioreactors microshoot cultures, RW2—extract of 20-days bioreactors microshoot cultures, RW3—extract of N. officinale herb. For compound numbers, refer to Table 2.
Phenolic profile and contents of detected compounds in N. officinale extracts from bioreactor microshoots cultures and from the herb of the parent plant confirmed by UHPLC-DAD-ESI-MS and HPLC-DAD.
| No. | Compound | UV-Vis | [M − H]-
| MS2 Ions | Content (mg/100 g DW ± SD) | |||
|---|---|---|---|---|---|---|---|---|
| In Vitro Cultures | Plant Material | |||||||
| Growth Cycles (Days) | ||||||||
| 10 Days | 20 Days | |||||||
| 9 | Gallic acid s | 3.4 | 269 | 169 | 125 | nd | nd | 26.55 ± 4.72 |
| 10 | Protocatechuic acid s | 4.1 | 258, 287 | 152 | - | nd | nd | 196.11 ± 18.23 |
| 11 | Undefined compound | 9.7 | 260 | 426 | - | nd | nd | nd |
| 12 | Undefined compound | 15.0 | 253 | 283 | - | nd | nd | nd |
| 13 | Undefined compound | 16.2 | 250 | 337 | - | nd | nd | nd |
| 14 | Protocatechuic acid derivative | 20.4 | 258, 287 | 387 | 153 | nd | nd | nd |
| 15 | Caffeic acid derivative | 22.1 | 280, 323 | 325 | 163 | nd | nd | nd |
| 16 | Undefined compound | 22.9 | 264 | 417 | 207 | nd | nd | nd |
| 17 | Phenolic acid derivative | 24.8 | 295, 309 | 431 | 385, 223 | nd | nd | nd |
| 18 | Caffeic acid derivative | 25.3 | 297, 325 | 355 | 265, 217, 193 | nd | nd | nd |
| 19 | Gluconasturtiin s | 28.1 | 220 | 422 | 342, 259, 229, 180 | nd | nd | nd |
| 20 | Glucohirsutin t | 28.4 | 220 | 492 | 428, 275 | nd | nd | nd |
| 21 | Phenolic acid derivative | 28.8 | 300, 318 | 308 | 175 | nd | nd | nd |
| 22 | Caffeic acid derivative | 33.3 | 298, 323 | 363 | 319, 244, 161 | nd | nd | nd |
| 23 | Caffeic acid derivative | 35.3 | 300, 328 | 695 | 651, 489 | nd | nd | nd |
| 24 | 36.7 | 313 | 163 | 133 | 1.26 ± 0.02 | 1.05 ± 0.01 | 3.10 ± 0.21 | |
| 25 | Ferulic acid s | 39.9 | 260, 327 | 193 | - | 9.28 ± 0.87 | 1.66 ± 0.23 | 12.69 ± 1.13 |
| 26 | Rutoside s | 41.3 | overlaped | 609 | 301 | 3.06 ± 0.28 | 23.24 ± 1.98 | 7.20 ± 0.67 |
| 27 | Isoquercitrin s | 42.1 | 260, 351 | 463 | 301 | nd | nd | 57.05 ± 5.11 |
| 28 | Kaempferol | 45.6 | 260, 341 | 593 | 447, 285 | nd | nd | 0.18 ± 0.02 |
| 29 | Sinapic acid derivative | 51.3 | 264, 336 | 753 | 529, 289, 223 | nd | nd | nd |
| 30 | Undefined compound | 66.8 | 230 | 329 | - | nd | nd | nd |
| 31 | Undefined compound | 71.9 | 225 | 307 | 289, 235, 185 | nd | nd | nd |
| 32 | Undefined compound | 73.7 | 231 | 311 | 293, 181, 155 | nd | nd | nd |
s—authentic standard was used for comparison, t—tentative assignment, nd-not detected. Data expressed as the mean value ± SD (n = 3).
Figure 3UHPLC-DAD-ESI-MS chromatogram of N. officinale extract from bioreactors cultures and the herb of the parent plant separation of the phenolic compounds (at 254 and 325 nm). For compound numbers, refer to Table 3. RW1—extract of N. officinale herb, RW4—extract of N. officinale bioreactors microshoot cultures.
Antioxidant potential estimated by CUPRAC, FRAP and DPPH methods (expressed in mmol TE/100 g DW ± SD) in N. officinale extracts from bioreactor microshoot cultures and from the herb of the parent plant.
| Method | In Vitro Cultures | Plant Material | |
|---|---|---|---|
| Growth Cycles (Days) | |||
| 10 Days | 20 Days | ||
| CUPRAC | 3.19 ± 0.20 | 2.46 ± 0.12 | 4.45 ± 0.02 |
| FRAP | 0.75 ± 0.05 | 0.67 ± 0.20 | 0.76 ± 0.08 |
| DPPH | 21.63 ± 2.77 | 23.79 ± 3.62 | 26.32 ± 8.23 |
CUPRAC—CUPric reducing antioxidant activity, FRAP—Ferric Reducing Ability of Plasma, DPPH—1,1-diphenyl-2-picrylhydrazyl assays; TE—trolox equivalent. Data expressed as the mean value ± SD (n = 3).
In vitro inhibition activity (%Inh ± SD) of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts against 15-LOX, COX-1, COX-2 and sPLA2 enzymes.
| Material | Concentrations (µg/mL) | %Inh ± SD | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 15-LOX | COX-1 | COX-2 | sPLA2 | ||||||
| In vitro cultures | 165.0 | no inhibition | 33.3 ± 3.7 | 34.5 ± 3.8 | 3.8 ± 0.2 | ||||
| 16.5 | 15.9 ± 1.1 | 40.5 ± 4.5 | 73.5 ± 8.1 | 1.3 ± 0.1 | |||||
| 1.7 | no inhibition | 29.2 ± 3.2 | 75.4 ± 8.3 | 0.7 ± 0.1 | |||||
| Plant material | 165.0 | no inhibition | 41.1 ± 4.5 | 39.8 ± 4.4 | 2.1 ± 0.1 | ||||
| 16.5 | 19.5 ± 1.4 | 36.3 ± 4.0 | 41.1 ± 4.5 | no inhibition | |||||
| 1.7 | no inhibition | 42.6 ± 4.7 | 33.0 ± 3.6 | 5.3 ± 0.2 | |||||
| Control | NDGA | 30.2 (100 µM) | 23.0 ± 2.0 | - | - | - | - | - | - |
| Ibuprofen | 2.1 (10 µM) | - | - | 23.0 ± 2.5 | 21.0 ± 2.0 | - | - | ||
| Thioetheramide-PC | 73.6 (100 µM) | - | - | - | - | - | - | 91.0 ± 4.0 | |
15-LOX—15-lipoxygenase, COX-1 and -2, cyclooxygenase-1 and -2, sPLA2—phospholipase A2 enzymes; %Inh—percent of enzyme activity inhibition; SD—standard deviation (n = 3), NDGA—nordihydroguaiaretic acid; Thioetheramide-PC—1-palmitylthio-2-palmitoylamido-1,2-dideoxy-sn-glycero-3-phosphorylcholine.
Antimicrobial activity of studied extracts from N. officinale microshoot cultures grown in RITA® bioreactors over 10 days growth periods, and N. officinale herb extracts, against selected bacterial and fungi strains.
| Microorganism | In Vitro Cultures | Plant Material | |||||
|---|---|---|---|---|---|---|---|
| MIC (mg/mL) | MBC or MFC (mg/mL) | MBC/MIC or MFC/MIC Ratio | MIC (mg/mL) | MBC or MFC (mg/mL) | MBC/MIC or MFC/MIC Ratio | ||
|
| 5 | 10 | 2 | 5 | 10 | 2 | |
| 5 | 20 | 4 | 5 | 20 | 4 | ||
| 5 | 10 | 2 | 10 | 10 | 1 | ||
|
| 10 | 10 | 1 | 10 | 10 | 1 | |
| 10 | 10 | 1 | 10 | 10 | 1 | ||
| 1.25 | 1.25 | 1 | 1.25 | 1.25 | 1 | ||
|
| 10 | 20 | 2 | 5 | 10 | 2 | |
| 20 | 20 | 1 | 10 | 20 | 2 | ||
| 10 | 10 | 1 | 10 | 10 | 1 | ||
| 10 | >20 | nd | 10 | >20 | nd | ||
| 10 | >20 | nd | 10 | >20 | nd | ||
| 1.25 | 2.5 | 2 | 2.5 | 2.5 | 1 | ||
| 5 | 20 | 4 | 10 | 20 | 2 | ||
nd—not detected; MIC—minimal inhibitory concentration; MBC—minimum bactericidal concentration; MFC—minimum fungicidal concentration.